Recent developments in mycobacterial research

Andries J C Steyn, John Chan, Vijay Mehra

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Tuberculosis remains a major health problem in the world, which is compounded further by the alarmingly high rate of M. tuberculosis infections in AIDS patients. Thus, there is an urgent need to advance our understanding of the mycobacterium to develop new drugs. The extraordinary recent developments in mycobacterial genetic research, particularly in genomics will greatly facilitate this goal. The knowledge of the entire genome sequence of M. tuberculosis will help in designing new chemotherapeutic and immunotherapeutic interventions. This review highlights recent developments in genomics, mycobacterial genetics, novel vaccine strategies, and our understanding of tuberculous dormancy.

Original languageEnglish (US)
Pages (from-to)415-424
Number of pages10
JournalCurrent Opinion in Infectious Diseases
Volume12
Issue number5
StatePublished - 1999

Fingerprint

Tuberculosis
Genomics
Research
Genetic Research
Mycobacterium
Acquired Immunodeficiency Syndrome
Vaccines
Genome
Health
Infection
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Microbiology (medical)
  • Immunology

Cite this

Recent developments in mycobacterial research. / Steyn, Andries J C; Chan, John; Mehra, Vijay.

In: Current Opinion in Infectious Diseases, Vol. 12, No. 5, 1999, p. 415-424.

Research output: Contribution to journalArticle

Steyn, AJC, Chan, J & Mehra, V 1999, 'Recent developments in mycobacterial research', Current Opinion in Infectious Diseases, vol. 12, no. 5, pp. 415-424.
Steyn, Andries J C ; Chan, John ; Mehra, Vijay. / Recent developments in mycobacterial research. In: Current Opinion in Infectious Diseases. 1999 ; Vol. 12, No. 5. pp. 415-424.
@article{15a4e2c7d40a43fe9c00c84c934aa2fb,
title = "Recent developments in mycobacterial research",
abstract = "Tuberculosis remains a major health problem in the world, which is compounded further by the alarmingly high rate of M. tuberculosis infections in AIDS patients. Thus, there is an urgent need to advance our understanding of the mycobacterium to develop new drugs. The extraordinary recent developments in mycobacterial genetic research, particularly in genomics will greatly facilitate this goal. The knowledge of the entire genome sequence of M. tuberculosis will help in designing new chemotherapeutic and immunotherapeutic interventions. This review highlights recent developments in genomics, mycobacterial genetics, novel vaccine strategies, and our understanding of tuberculous dormancy.",
author = "Steyn, {Andries J C} and John Chan and Vijay Mehra",
year = "1999",
language = "English (US)",
volume = "12",
pages = "415--424",
journal = "Current Opinion in Infectious Diseases",
issn = "0951-7375",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Recent developments in mycobacterial research

AU - Steyn, Andries J C

AU - Chan, John

AU - Mehra, Vijay

PY - 1999

Y1 - 1999

N2 - Tuberculosis remains a major health problem in the world, which is compounded further by the alarmingly high rate of M. tuberculosis infections in AIDS patients. Thus, there is an urgent need to advance our understanding of the mycobacterium to develop new drugs. The extraordinary recent developments in mycobacterial genetic research, particularly in genomics will greatly facilitate this goal. The knowledge of the entire genome sequence of M. tuberculosis will help in designing new chemotherapeutic and immunotherapeutic interventions. This review highlights recent developments in genomics, mycobacterial genetics, novel vaccine strategies, and our understanding of tuberculous dormancy.

AB - Tuberculosis remains a major health problem in the world, which is compounded further by the alarmingly high rate of M. tuberculosis infections in AIDS patients. Thus, there is an urgent need to advance our understanding of the mycobacterium to develop new drugs. The extraordinary recent developments in mycobacterial genetic research, particularly in genomics will greatly facilitate this goal. The knowledge of the entire genome sequence of M. tuberculosis will help in designing new chemotherapeutic and immunotherapeutic interventions. This review highlights recent developments in genomics, mycobacterial genetics, novel vaccine strategies, and our understanding of tuberculous dormancy.

UR - http://www.scopus.com/inward/record.url?scp=0032805930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032805930&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 415

EP - 424

JO - Current Opinion in Infectious Diseases

JF - Current Opinion in Infectious Diseases

SN - 0951-7375

IS - 5

ER -